Kajantie E, Osmond C, Eriksson ]G: Gestational hypertension is associated with increased risk of type 2 diabetes in adult ofspring: the Helsinki Birth Cohort Study. Am] Obstet Gynecol 216(3):281.e 1, 2017
Karumanchi SA: Angiogenic factors in preeclampsia from diagnosis to therapy.
Hypertension 67:n1072, 2016a
Karumanchi SA, Granger ]P: Preeclampsia and pregnancy-related hypertensive disorders. Hypertension 67:238, 2016b
Karumanchi SA, Stillman IE, Lindheimer MD: Angiogenesis and preeclampsia. In Lindheimer MD, Roberts ]M, Cunningham FG (eds): Chesley's Hypertensive Disorders of Pregnancy, 3rd ed. New York, Elsevier, 2009
Kasawara KT, do Nascimento SL, Costa ML, et al: Exercise and physical activity in the prevention of pre-eclampsia: systematic review. Acta Obstet Gynecol Scand 91(10):1147,n2012
Kashanian M, Koohpayehzadeh], Sheikhansari N, et al: A comparison berween the rwo methods of magnesium sulfate administration for dutation of 12 versus 24 h after delivery in patients with severe preeclampsia. ] Matern Fetal Neonatal Med 29(14):2282, 2016
Katz L, de Amorim MM, Figueroa ]N, et al: Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am ] Obstet Gynecol 198:283.e 1, 2008
Keiser S, Owens M, Parrish M, et al: HELLP syndrome with and without eclampsia. Am] Perinatol 28(3):187, 2011 Kenny L, McCrae K, Cunningham FG: Platelets, coagulation, and the liver.
In Taylor RN, Roberts ]M, Cunningham FG (eds): Chesley's Hypertensive
Disorders in Pregnancy, 4th ed. Amsterdam, Academic Press, 20n15
Khalil A, Akolekar R, Syngelaki A, et al: Maternal hemodynamics at 11-13 weeks' gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol 40(1):28,n2012
Khan KS, Wojdyla 0, Say L, et al: WHO analysis of causes of maternal death: a systematic review. Lancet 367: 1 066, 2006
Khodzhaeva ZS, Kogan YA, Shmakov RG, et al: Clinical and pathogenetic features of early-and late-onset preeclampsia. ] Matern Fetal Neonatal Med 29(18):2980,n2016
Kim MY, Buyon ]P, Guerra MM, et al: Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am] Obstet Gynecol 214:108.e1,2016
Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, et al: Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of preeclampsia: a systematic review and meta-analysis. B]OG 8,2012